Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-27 Sale | 2023-10-31 5:00 pm | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 50,012 | $9.82 | $491,118 | 342,845 (Direct) | View |
| 2022-06-01 Purchase | 2022-06-02 4:29 pm | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 16,000 | $0.6118 | $9,789 | 16,000 (Direct) | View |
| 2021-04-30 Sale | 2021-05-04 8:00 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 3,172 | $4.86 | $15,416 | 96,097 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 8:00 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 3,413 | $7.71 | $26,314 | 99,269 (Direct) | View |
| 2020-11-02 Sale | 2020-11-03 8:04 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 3,280 | $3.79 | $12,431 | 102,682 (Direct) | View |
| 2020-07-31 Sale | 2020-08-04 9:21 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 3,133 | $4.2 | $13,159 | 105,962 (Direct) | View |
| 2020-04-30 Sale | 2020-05-04 6:07 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 3,075 | $1.79 | $5,504 | 62,986 (Direct) | View |
| 2020-01-31 Sale | 2020-02-03 8:00 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 2,654 | $1.96 | $5,202 | 66,061 (Direct) | View |
| 2019-10-31 Sale | 2019-11-01 8:00 pm | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 2,128 | $2.16 | $4,596 | 68,715 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Disposition | 2024-03-07 5:46 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 2,039,487 | $0 | 0 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 9:45 pm | N/A 2034-01-04 | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 1,666 | $0 | 1,666 (Direct) | View |
| 2023-12-11 Option Award | 2023-12-11 5:15 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 750,000 | $0 | 1,363,332 (Direct) | View |
| 2023-07-05 Option Award | 2023-07-07 4:06 pm | N/A 2033-07-05 | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 1,216,500 | $0 | 1,216,500 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-28 5:59 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 2,750,000 | $0 | 2,750,000 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-05 7:20 pm | N/A 2033-01-05 | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2023-01-03 6:35 pm | N/A 2032-10-31 | Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO | 0 | $0 | 5,410,000 (Direct) | View |
| 2022-12-12 Other | 2022-12-14 7:21 pm | 2022-12-12 N/A | ZyVersa Therapeutics Inc. | ZVSA | O'Connor Daniel J. Larkspur Health LLC Director 10% Owner | 1,558,302 | $0 | 2,935,900 (Direct) | View |
| 2022-01-06 Other | 2022-03-10 5:31 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | O'Connor Daniel J. Chief Executive Officer | 66,018 | $0 | 487,097 (Indirect) | View |
| 2022-01-05 Option Award | 2022-01-06 8:06 pm | N/A 2032-01-05 | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 35,000 | $0 | 35,000 (Direct) | View |
Ownership | 2021-12-20 6:23 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | O'Connor Daniel J. Chief Executive Officer | 0 | $0 | 224,643 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 4:29 pm | N/A 2031-01-06 | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2020-08-24 Option Award | 2020-08-26 8:00 pm | 2020-11-24 2030-08-24 | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 152,000 | $0 | 152,000 (Direct) | View |
| 2020-05-29 Tax Withholding | 2020-06-03 9:05 pm | N/A N/A | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 44,471 | $2.23 | 413,095 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-03 9:05 pm | 2020-04-14 2030-04-14 | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 394,580 | $0 | 413,095 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-07 4:32 pm | N/A 2030-01-06 | SEELOS THERAPEUTICS INC. | SEEL | O'Connor Daniel J. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2019-07-31 Tax Withholding | 2019-08-02 6:00 pm | N/A N/A | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 2,156 | $2.23 | 70,843 (Direct) | View |
| 2019-04-30 Tax Withholding | 2019-05-02 4:15 pm | N/A N/A | ONCOSEC MEDICAL Inc | ONCS | O'Connor Daniel J. CEO and President | 21,357 | $0.565 | 729,992 (Direct) | View |